ANNUAL REPORT 2012 - TiGenix
ANNUAL REPORT 2012 - TiGenix
ANNUAL REPORT 2012 - TiGenix
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Remuneration of the audit committee in <strong>2012</strong><br />
In <strong>2012</strong>, the following amounts were accrued for fees of the independent directors as member of<br />
the audit committee for the performance of their mandate during the financial year <strong>2012</strong> :<br />
Name Name Fee<br />
Willy Duron<br />
Chairman of the audit committee;<br />
7,500<br />
Independent Director<br />
Eduard Enrico Holdener (1)<br />
Member of the audit committee;<br />
3,750<br />
Independent Director<br />
Innosté SA, represented by Jean Stéphenne (2) Member of the audit committee;<br />
1,250<br />
Chairman of the Board of Directors;<br />
Independent Director<br />
LRM Beheer NV, represented<br />
Member of the audit committee;<br />
-<br />
by Nico Vandervelpen<br />
Director (non-executive)<br />
TOTAL 12,500<br />
(1)<br />
Eduardo Enrico Holdener was a member of the audit committee until September 19, <strong>2012</strong>.<br />
(2)<br />
Innosté SA, represented by Jean Stéphenne, has been a member of the audit committee since September 19, <strong>2012</strong>.<br />
Remuneration of the nomination and remuneration committee in <strong>2012</strong><br />
In <strong>2012</strong>, the following amounts were accrued for fees of the independent directors as member of<br />
the nomination and remuneration committee for the performance of their mandate during the<br />
financial year <strong>2012</strong> :<br />
Name Name Fee<br />
R&S Consulting BVBA, represented by Dirk Reyn (1) Chairman of the nomination<br />
11,625<br />
and remuneration committee;<br />
Independent Director<br />
Greig Biotechnology Global Consulting, Inc., Member of the nomination<br />
1,250<br />
represented by Russell G. Greig (2)<br />
and remuneration committee;<br />
Independent Director<br />
Eduard Enrico Holdener (3)<br />
Member of the nomination<br />
and remuneration committee;<br />
Independent Director<br />
12,875<br />
Ysios Capital Partners SGECR SA, represented by<br />
Joël Jean-Mairet (4)<br />
Member of the nomination and<br />
remuneration committee; Director<br />
(non-executive)<br />
TOTAL 25,750<br />
(1)<br />
R&S <br />
Consulting BVBA, represented by Dirk Reyn, was appointed Chairman of the nomination and remuneration committee as of<br />
September 19, <strong>2012</strong>.<br />
(2)<br />
Greig Biotechnology Global Consulting, Inc., represented by Russell G. Greig, has been a member of the nomination and<br />
remuneration committee since September 19, <strong>2012</strong>.<br />
(3)<br />
Eduard Enrico Holdener was Chairman of the nomination and remuneration committee until September 19, <strong>2012</strong>.<br />
(4)<br />
Ysios Capital Partners SGECR SA, represented by Joël Jean-Mairet, was a member of the nomination and remuneration<br />
committee until September 19, <strong>2012</strong>.<br />
-<br />
186 <strong>TiGenix</strong> I annual report <strong>2012</strong>